Funder
University of Colombo
NIH/USA
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Control of the leishmaniases. Report of a meeting of the WHO expert committee on the control of leishmaniasis, 2010. Contract No: 949.
http://apps.who.int/iris/bitstream/handle/10665/44412/WHO_TRS_949_eng.pdf?sequence=1&isAllowed=y
. Accessed 30 Dec 2018.
2. Karunaweera ND, Ferreira MU. Leishmaniasis: current challenges and prospects for elimination with special focus on the south Asian region. Parasitology. 2018;145:425–9.
3. Siriwardena HV, Udagedara CU, Karunaweera ND. Clinical features, risk factors and efficacy of cryotherapy in cutaneous leishmaniasis in Sri Lanka. Ceylon Med J. 2003;48(1):10–2.
4. Karunaweera ND, Pratlong F, Siriwardane HVYD, Ihalamulla RL, Dedet JP. Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37. Trans Royal Soc Trop Med Hyg. 2003;97:380–1.
5. Siriwardana HVYD, Noyes HA, Beeching NJ, Chance ML, Karunaweera ND, Bates PA. Leishmania donovani and cutaneous leishmaniasis, Sri Lanka. Emerg Infect Dis. 2007;13(3):476–8.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献